Genetic susceptibility, smoking, obesity and risk of venous thromboembolism: Research paper

British Journal of Haematology

Volumn 149, Issue 2, 2010, Pages 273-279

  Severinsen, Marianne T ^a   Overvad, Kim ^a,b   Johnsen, Søren P ^a   Dethlefsen, Claus ^a   Madsen, Poul H ^b   Tjønneland, Anne ^c   Kristensen, Søren R ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

F2 G20210A (prothrombin) mutation; F5 G1691A (Factor V Leiden F5) mutation; Obesity; Smoking; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VENOUS THROMBOEMBOLISM; WILD TYPE;

BODY WEIGHT; DENMARK; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MUTATION; OBESITY; PROSPECTIVE STUDIES; PROTHROMBIN; SMOKING; VENOUS THROMBOEMBOLISM;

EID: 77949804570     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08086.x     Document Type: Article

References (31)

1. Abdollahi, M., Cushman, M. Rosendaal, F.R. (2003) Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thrombosis and Haemostasis, 89, 493 498.
2. Cattaneo, M., Chantarangkul, V., Taioli, E., Santos, J.H. Tagliabue, L. (1999) The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thrombosis Research, 93, 1 8.
3. Dahlback, B. (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood, 112, 19 27.
4. Darvall, K.A., Sam, R.C., Silverman, S.H., Bradbury, A.W. Adam, D.J. (2007) Obesity and thrombosis. European Journal of Vascular and Endovascular Surgery, 33, 223 233.
5. Emmerich, J., Rosendaal, F.R., Cattaneo, M., Margaglione, M., De, S.V., Cumming, T., Arruda, V., Hillarp, A. Reny, J.L. (2001) Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thrombosis and Haemostasis, 86, 809 816.
6. Folsom, A.R., Cushman, M., Tsai, M.Y., Heckbert, S.R. Aleksic, N. (2002) Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. American Journal of Hematology, 71, 285 290.
7. Juul, K., Tybjaerg-Hansen, A., Schnohr, P. Nordestgaard, B.G. (2004) Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Annals of Internal Medicine, 140, 330 337.
8. Kalbfleisch, J.D. Lawless, J.F. (1988) Likelihood analysis of multi-state models for disease incidence and mortality. Statistics in Medicine, 7, 149 160.
9. Kristensen, S.R., Andersen-Ranberg, K., Bathum, L. Jeune, B. (1998) Factor V Leiden and venous thrombosis in Danish centenarians. Thrombosis and Haemostasis, 80, 860 861.
10. Kyrle, P.A. Eichinger, S. (2005) Deep vein thrombosis. The Lancet, 365, 1163 1174.
11. Mertens, I. Van Gaal, L.F. (2002) Obesity, haemostasis and the fibrinolytic system. Obesity Reviews, 3, 85 101.
12. Miller, S.A., Dykes, D.D. Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
13. Miller, G.J., Bauer, K.A., Cooper, J.A. Rosenberg, R.D. (1998) Activation of the coagulant pathway in cigarette smokers. Thrombosis and Haemostasis, 79, 549 553.
14. de Mutsert, R., Jager, K.J., Zoccali, C. Dekker, F.W. (2009) The effect of joint exposures: examining the presence of interaction. Kidney International, 75, 677 681.
15. Naess, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. Hammerstrom, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692 699.
16. Nossent, A.Y., Eikenboom, J.C. Bertina, R.M. (2007) Plasma coagulation factor levels in venous thrombosis. Seminars in Hematology, 44, 77 84.
17. Pabinger, I. Ay, C. (2009) Biomarkers and venous thromboembolism. Arteriosclerosis, Thrombosis and Vascular Biology, 29, 332 336.
18. Pomp, E.R., le, C.S., Rosendaal, F.R. Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289 296.
19. Pomp, E.R., Rosendaal, F.R. Doggen, C.J. (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83, 97 102.
20. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698 3703.
21. Rosito, G.A., D'Agostino, R.B., Massaro, J., Lipinska, I., Mittleman, M.A., Sutherland, P., Wilson, P.W., Levy, D., Muller, J.E. Tofler, G.H. (2004) Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thrombosis and Haemostasis, 91, 683 689.
22. Severinsen, M.T., Kristensen, S.R., Johnsen, S.P., Dethlefsen, C., Tjonneland, A. Overvad, K. (2009) Smoking and venous thromboembolism: a Danish follow-up study. Journal of Thrombosis and Haemostasis, 7, 1297 1303.
23. Severinsen, M.T., Kristensen, S.R., Overvad, K., Dethlefsen, C., Tjonneland, A. Johnsen, S.P. (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. Journal of Clinical Epidemiology, 63, 223 228.
24. Simioni, P., Tormene, D., Manfrin, D., Gavasso, S., Luni, S., Stocco, D. Girolami, A. (1998) Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. British Journal of Haematology, 103, 1045 1050.
25. Thorelli, E., Kaufman, R.J. Dahlback, B. (1999) Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood, 93, 2552 2558.
26. Tjonneland, A., Olsen, A., Boll, K., Stripp, C., Christensen, J., Engholm, G. Overvad, K. (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scandinavian Journal of Public Health, 35, 432 441.
27. Tripodi, A. (2003) Levels of coagulation factors and venous thromboembolism. Haematologica, 88, 705 711.
28. Wannamethee, S.G., Lowe, G.D., Shaper, A.G., Rumley, A., Lennon, L. Whincup, P.H. (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26, 1765 1773.
29. Weischer, M., Juul, K., Zacho, J., Jensen, G.B., Steffensen, R., Schroeder, T.V., Tybjaerg-Hansen, A. Nordestgaard, B.G. (2010) Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population. Atherosclerosis, 208, 480 483.
30. Yanbaeva, D.G., Dentener, M.A., Creutzberg, E.C., Wesseling, G. Wouters, E.F. (2007) Systemic effects of smoking. Chest, 131, 1557 1566.
31. Yarnell, J.W., Sweetnam, P.M., Rumley, A. Lowe, G.D. (2001) Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagulation and Fibrinolysis, 12, 721 728.